Other Aggressive Lymphomas
Mantle Cell Lymphoma
Mantle cell lymphoma: an entity comes of age.
Weisenburger DD, Armitage JO.
Blood. 1996;87:4483-4494.
Description: Good review includes pathology, diagnosis, and outcomes.
PubMed citation number: 8639814
Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Yatabe Y, Suzuki R, Tobinai K, et al.
Blood. 2000;95:2253-2261.
Description: Using immunohistochemistry, found subgroups of MCL that were cyclin D1 positive or negative, corresponding with different patient characteristics and clinical courses.
PubMed citation number: 10733493
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Rosenwald A, Wright G, Wiestner A, et al.
Cancer Cell. 2003;3:185-197.
Description: Expression profiling identified subsets of MCL with different prognoses.
PubMed citation number: 12620412
T-Cell Lymphomas
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification
Lopez-Guillermo A, Cid J, Salar A, et al.
Ann Oncol. 1998;9:849-855.
Description: Describes the initial characteristics and prognostic factors in a large series of PTCL patients. PubMed citation number: 9789607
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
Rudiger T, Weisenburger DD, Anderson JR, et al: Non- Hodgkin's Lymphoma Classification Project.
Ann Oncol. 2002;13:140-149.
Description: Peripheral T-cell lymphoma (PTCL) is rare in most parts of the world. The authors evaluated the 96 cases of PTCL diagnosed within the Non-Hodgkin's Lymphoma Classification Project (NHLCP; 1378 cases) for their geographical distribution, pathologic features, and diagnostic reliability, as well as clinical presentation and outcome.
PubMed citation number: 11863096
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Stein H, Foss HD, Durkop H, et al.
Blood. 2000;96:3681.
Description: This review article describes the different variants of anaplastic large-cell lymphoma.
PubMed citation number: 11090048
Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Gascoyne RD , Aoun P, Wu D, et al.
Blood. 1999;93:3913-3921.
Description: Describes the variants of anaplastic lymphoma and establishes ALK expression as a prognostic indicator, in addition to LDH and IPI score. (There is still some controversy about this.)
PubMed citation number: 10339500
Other Aggressive Lymphomas
Primary mediastinal B cell lymphoma: a review of pathology and management.
Van Besien K, Kelta M, Bahaguna P.
J Clin Oncol. 2001;19:1855-1864.
Description: Review of a distinct subtype of diffuse large-cell NHL. This review includes diagnosis, pathology, staging, and treatment options.
PubMed citation number: 11251018
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Rodriguez J, McLaughlin P, Hagemeister FB, et al.
Blood. 1999;93:2202-2207.
Description: This study looks at 100 cases of follicular large-cell lymphoma (FLCL) that were treated with chemotherapy and followed, and describes outcomes based on pretreatment features such as IPI.
PubMed citation number: 10090928
Lymphoblastic lymphoma.
Thomas DA, Kantarjian HM.
Hematology Oncol Clin North Am. 2001;15:51-95.
Description: Review includes diagnosis, pathology, and treatment.
PubMed citation number: 11253609
Treatment
Adults and children with small non-cleaved cell lymphoma have similar excellent outcomes when treated with the same chemotherapy regimen.
Magrath I, Adde M, Shad A, et al.
J Clin Oncol. 1996;14:925-934.
Description: This study supports the clinical practice of using pediatric regimen (CODOX-M-IVAC) in adult Burkitt lymphoma.
PubMed citation number: 8622041
Chemotherapy for Human Immunodeficiency virus associated Non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy.
Lee R, Lee J, Tang S, et al.
J Clin Oncol. 2001;19:2171-2178.
Description: Prospective study shows that full-dose CHOP with growth-factor support can be administered concurrently with HAART therapy for HIV.
PubMed citation number: 11304769